Standard Biotools (LAB) Debt to Equity (2021 - 2024)
Historic Debt to Equity for Standard Biotools (LAB) over the last 7 years, with Q3 2024 value amounting to $0.11.
- Standard Biotools' Debt to Equity rose 25373.51% to $0.11 in Q3 2024 from the same period last year, while for Sep 2024 it was $0.11, marking a year-over-year increase of 25373.51%. This contributed to the annual value of -$0.39 for FY2023, which is 21025.05% down from last year.
- Latest data reveals that Standard Biotools reported Debt to Equity of $0.11 as of Q3 2024, which was up 25373.51% from $0.11 recorded in Q2 2024.
- In the past 5 years, Standard Biotools' Debt to Equity registered a high of $0.46 during Q1 2022, and its lowest value of -$0.39 during Q4 2023.
- For the 4-year period, Standard Biotools' Debt to Equity averaged around -$0.01, with its median value being -$0.07 (2023).
- As far as peak fluctuations go, Standard Biotools' Debt to Equity plummeted by 26178.06% in 2022, and later surged by 25373.51% in 2024.
- Over the past 4 years, Standard Biotools' Debt to Equity (Quarter) stood at $0.18 in 2021, then tumbled by 170.67% to -$0.13 in 2022, then crashed by 210.25% to -$0.39 in 2023, then surged by 128.67% to $0.11 in 2024.
- Its Debt to Equity was $0.11 in Q3 2024, compared to $0.11 in Q2 2024 and $0.09 in Q1 2024.